Effect Of Glycosylation And Physico-chemical Properties On Biological Activity Of Anti-HER2 Molecule | 97826
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

6th International Conference on Vaccines and Immunology

Geneva, Switzerland

3rd European Congress on Virology

Geneva, Switzerland
Google Scholar citation report
Citations : 1600

Journal of Biotechnology & Biomaterials received 1600 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Effect of glycosylation and physico-chemical properties on biological activity of anti-HER2 molecule

Joint Event on 24th Biotechnology Congress: Research & Innovations & Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

Sourav Majumdar, Jayachandran Ramalingama and Sunil Gairolaa

Serum institute of India Pvt Ltd Pune, India

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X-C4-097

Background: The biological activity of an anti-HER2 molecule is profoundly influenced by the microheterogeneity of the N-linked glycan profile. A minor change in glycan profile of anti-HER2 molecule during post-translational modification showed an impact on its biological activity, Pharmacokinetics (PK) as well as the stability of the molecule. The complexities in glycan pattern of anti-HER2 molecule further encourage the need of new analytical challenges in evaluating the comparability with innovator molecule in recent scenario. Aim/Objective: A comparison of glycan profiling and binding kinetics including charge variant heterogeneity analysis of anti- HER2 molecule with innovator molecule was aimed for the current investigation. Methodology: In the current investigation, The PNGase F digestion of anti-HER2 molecule followed by UPLC analysis under Normal phase liquid chromatographic conditions using a platform approach to establish the chromatographic profile of various Glycan residues such as G0, G0F, GIFa and GIFb, G2F. Further, binding with the HER2 receptor under in vitro conditions through Biocore T200 analysis was evaluated to demonstrate the binding kinetics. Additionally, charge variant heterogeneity was subjected as a part of extensive characterization to evaluate the anti-HER2 molecule in comparison with innovator molecule. Results and Discussion: Anti-HER2 molecule with a mass of 148kDa was purified and a comparison against innovator molecule in glycan profiling was identified by predominant residues, which represent 90% of the glycosylation profile of the anti-HER2 molecule. The terminal galactosylation and fucosylation of glycan residues influence the CDC and ADCC activity, respectively. The variability in the glycan profile can thus affect the biological activity. Further, the high mannose content in anti-HER2 molecule showed the early clearance and provides a strong impact on its PK. Additionally, binding with a HER2 receptor under in vitro conditions through Biocore T200 analysis was evaluated to demonstrate the binding kinetics. The dynamic binding nature of anti-HER2 molecule (6.21x10-10M) and innovator molecule (6.95x10-10 M) showed the closeness of KD value. Moreover, the weak binding of acidic variants with HER2 receptor also provides an impact on ADCC activity and hence, charge variant analysis was shown to be equally important to demonstrate the efficacy of the anti-HER2 molecule. Acidic variant (K0, deamidated Asn) and basic variants (K1, K2) were determined by cation exchange chromatography (CEX) and percentage of acidic variant (<35%) were evaluated based on separation on cation exchange column in UHPLC system. The comparisons were carried out based on the response of reference standard peaks under the identical condition and determine the percentage of acidic variants. Conclusion: Overall, the efficacy and comparability aspects of the in-house anti-HER2 molecule were evaluated against the innovator???s molecule and attested its candidature as a ???Biosimilar??? in the pharmaceutical therapeutic domain.

Sourav Majumdar serves as a Deputy Manager in Serum Institute of India Pvt. Ltd, Pune. He has developed his core expertise in the area of Bioanalytical method development in proteomics platform. He is leading the group of biosimilar especially dealing with recombinant monoclonal antibody. After completion of his PhD degree he joined EPR Centre for cancer research, Hyderabad as ADL lead. He developed several analytical methods for routine and extensive characterization of mAb molecule. Formerly, he worked in Intas Bio Pharmaceutical R&D stability division as Senior Research Associate. He then joined for USV and was assigned to work on various recombinants Biosimilar Therapeutics with several analytical challenges especially with anticancer molecule. He joined as a Junior Research fellow in MBBT department for PhD His research was on a “Novel Fibrinolytic Enzyme and a comparison with commercially available Cardiovascular Drugs under in vitro and in vivo conditions”. He has his majors in Bio-Chemistry from University of Pune, 2004. He is a recipient of “National Level fellowship” and “Ratan Tata fellowship”. He was awarded the best speaker from Garware Chemical Association. He published a series of Research Article in reputed International Journals.

E-mail: [email protected]